Vimarsana
Biggest News Aggregation in the World

Suraksha Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Suraksha Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Suraksha Program Today - Breaking & Trending Today

Covid-19 booster dose iNCOVACC to enter India shortly, Bharat Biotech confirms - Vimarsana News

Covid-19 booster dose iNCOVACC to enter India shortly, Bharat Biotech confirms

INCOVACC is now available on CoWin, and priced at Rs 800 for private markets and priced at Rs 325 for supplies to government of India and state governments.

Nasal Vaccine Pricing Out, To be Rolled Out Around Last Week of January - Vimarsana News

Nasal Vaccine Pricing Out, To be Rolled Out Around Last Week of January

INCOVACC is to be priced at INR 325 per dose for large volume procurement by State Governments and Govt of India, and INR 800 for Private Markets.

Source: newsx.com
COVID-19: Government approves nasal vaccine, will be available first in private hospitals - Vimarsana News

COVID-19: Government approves nasal vaccine, will be available first in private hospitals

As of now, the situation is not alarming, so there is no need to panic, said a government press release.

Bharat Biotech's nasal Covid vaccine for adults gets Centre's nod, to be availabile in private hospitals - Vimarsana News

Bharat Biotech's nasal Covid vaccine for adults gets Centre's nod, to be availabile in private hospitals

The central government has approved the use of Bharat Biotech nasal Covid vaccine iNCOVACC to be included in the country vaccination programme as a booster

India made world's first COVID nasal vaccine gets approval: Dr Jitendra - Jammu Kashmir Latest News | Tourism - Vimarsana News

India made world's first COVID nasal vaccine gets approval: Dr Jitendra - Jammu Kashmir Latest News | Tourism

Excelsior Correspondent NEW DELHI, Dec 1 : World’s first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situations in the age group of 18 and above. This was informed here today by Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh while chairing the meeting […]